Therefore, despite the high concentration of K+ ions in tumors affecting the expression of Arg I and iNOS by MDSCs, these cells adapt and maintain their pathological immunomodulatory functions in the TME, as widely recognized in the literature from human and mouse cancer studies. This evidence concerns the gene LNCARGI and cancer.